Disinhibition and risk compensation: scope, definitions, and perspective

Sex Transm Dis. 2008 Dec;35(12):1009-10. doi: 10.1097/OLQ.0b013e31818eb752.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Adenine / administration & dosage
  • Adenine / analogs & derivatives
  • Adenine / therapeutic use
  • Anti-HIV Agents / administration & dosage
  • Anti-HIV Agents / therapeutic use
  • Chemoprevention
  • Clinical Trials as Topic
  • Counseling
  • Female
  • HIV Infections / prevention & control*
  • Humans
  • Male
  • Organophosphonates / administration & dosage
  • Organophosphonates / therapeutic use
  • Reverse Transcriptase Inhibitors / administration & dosage
  • Reverse Transcriptase Inhibitors / therapeutic use
  • Risk Reduction Behavior*
  • Safe Sex
  • Sex Work
  • Sexual Behavior
  • Sexually Transmitted Diseases / prevention & control*
  • Tenofovir

Substances

  • Anti-HIV Agents
  • Organophosphonates
  • Reverse Transcriptase Inhibitors
  • Tenofovir
  • Adenine